Companies form consortium to deliver robotics CGT manufacturing platform

Cellular Origins, a TTP company, focused on efficient robotic manufacture of cell and gene therapies (CGTs), the Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, and Resolution Therapeutics, a clinical-stage biopharmaceutical company, have announced the formation of a consortium.

The consortium has been awarded a cross-industry Smart Grant of £1 million from Innovate UK, UK’s national innovation agency.

The project aims to use novel technologies to…